Genetics and individual predispositions in contact dermatitis

Contact Dermatitis (Fifth Edition)

Volumn , Issue , 2011, Pages 13-42

  Schnuch, Axel ^a   Carlsen, Berit Christina ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857064251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-03827-3_2     Document Type: Chapter

References (260)

1. Schnuch A, Brasch J, Uter W (2008) Polysensitization and increased susceptibility in contact allergy: A review. Allergy 63:156-167.
2. Hardy J, Singleton A (2009) Genomwide association studies and human disease. N Engl J Med 360:1759-1768.
3. Landsteiner K, Rostenberg A, Sulzberger MB (1939) Individual differences in susceptibility to eczematous sensitization with simple chemical substances. J Invest Dermatol 2:25-29.
4. Hostynek JJ, Maibach HI (2004) Thresholds of elicitation depend on induction conditions. Could low level exposure induce sub-clinical allergic states that are only elicited under the severe conditions of clinical diagnosis? Food Chem Toxicol 42:1859-1865.
5. Menne T, Holm NV (1986) Genetic susceptibility in human allergic contact sensitization. Semin Dermatol 5:301-306.
6. Shram SE, Warshaw EM (2007) Genetics of nickel allergic contact dermatitis. Dermatitis 18:125-133.
7. Sulzberger MB, Rostenberg A (1939) Acquired specific supersensitivity (allergy) to simple chemicals. IV. A method of experiemntal sensitization; and demonstration of increased susceptibility in individuals with eczematous dermatitis of contact type. J Immunol 36:17-27.
8. Walker FB, Smith PD, Maibach HI (1967) Genetic factors in human allergic contact dermatitis. Int Arch Allergy Appl Immunol 32:453-462.
9. Menne T, Holm NV (1983) Nickel allergy in a female twin population. Int J Dermatol 22:22-28.
10. Forsbeck M, Skog E, Ytterborn KH (1971) Allergig diseases among relatives of patients with allergic contact dermatitis. Acta Derm Venereol (Stockh) 51:123-128.
11. Fleming CJ, Burden AD, Forsyth A (1999) The genetics of allergic contact hypersensitivity to nickel. Contact Dermat 41:251-253.
12. Forsbeck M, Skog E, Ytterborn KH (1968) Delayed type of allergy and atopic disease among twins. Acta Derm Venereol (Stockh) 48:192-197.
13. Bryld LE, Hindsberger C, Kyvik KO, Agner T, Menne T (2004) Genetic factors in nickel allergy evaluated in a population- based female twin sample. J Invest Dermatol 123: 1025-1029.
14. Bataille V (2004) Genetic factors in nickel allergy. J Invest Dermatol 123:xxiv-xxv.
15. Bataille V (1999) The role of twin studies in the genetics of skin diseases. Clin Exp Dermatol 24:286-290.
16. Holdsworth R, Hurley CK, Marsh SGE, Lau M, Noreen HJ, Kempenich JH, Setterholm M, Maiers M (2009) The HLA dictionary 2008: A summary of HLA-A, -B, -C, DRB1/3/4/5, and DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 73:95-170.
17. Fernando MM, Stevens CR, Walsh EC, DeJager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD (2008) Defining the role of the MHC in autoimmunity: A review and pooled analysis. PLoS Genet 4(4):e100024.doi:10.1371/journal.pgen.000024.
18. Ishii N, Ishii H, Ono H, Horiuchi Y, Nkajima H, Aoki I (1990) Genetic control of nickel sulfate delayed-type hypersensitivity. J Invest Dermatol 94:673-676.
19. Ishii N, Ishii H, Nakajima H, Aoki I, Shimoda N (1991) Contact sensitivity to mercuric chloride is associated with I-A region in mice. J Dermatol Sci 2:268-273.
20. Ishii N, Takahashi K, Kawaguchi H, Nakajima H, Tanaka S, Aoki I (1993) Genetic control of delayed-type hypersensitivity to chromium chloride. Int Arch Allergy Immunol 100:333-337.
21. Ishii N, Takahashi K, Ishiwa M, Sugita Y, Nakajima H (1998) Genetic control of delayed-type hypersensitivity to gold antigens in mice. J Dermatol Sci 16:104-110.
22. Okuda K, Ishii N, Ikezawa Z, Tani K, Ishigatsubo Y (1980) Genetic control of contact hypersensitivity. I. I-A subregion as well as non-H-2 loci codes for the gene of 2, 4-dinitro-1- fluorobenzene antigen. Eur J Immunol 10:969-971.
23. Kato H, Hayashi M, Fukumori Y, Kaneko H (2002) MHC restriction in contact hypersensitivity to dicyclohexylcarbodiimide. Food Chem Toxicol 40:1713-1718.
24. Emtestam L, Zetterquist H, Olerup O (1993) HLA-DR, -DQ and -DP alleles in nickel, chromium, and/or cobalt-sensitive individuals: genomic analysis based on restriction fragment length polymorphisms. J Invest Dermatol 100:271-274.
25. Walton S, Keczkes K, Learoyd PA, Rajah SM (1986) HLAA, -B and DR antigens in nickel sensitive females. Clin Exp Dermatol 11:636-640.
26. Önder M, Aksakal B, Gulekon A, Makki S, Gurer MA, Barut A (1995) HLA DR, DQA, DQB and DP antigens in patients allergic to nickel. Contact Dermat 33:434-435.
27. Silvennoinen-Kassinen S, Ikäheimo I, Tiilikainen A (1997) TAP1 and TAP2 genes in nickel allergy. Int Arch Allergy Immunol 114:94-96.
28. Orecchia G, Perfetti L, Finco O, Dondi E, Cuccia M (1992) Polymorphisms of HLA class III genes in allergic contact dermatitis. Dermatology 184:254-259.
29. Moulon C, Wild D, Dormoy A, Weltzien HU (1998) MHCdependent and -independent activation of human nickelspecific CD8+ cytotoxic T cells from allergic donors. J Invest Dermatol 111:360-366.
30. Gamerdinger K, Moulon C, Karp DR, VanBergen J, Koning F, Wild D, Pflugfelder U, Weltzien HU (2003) A new type of metal recognition by human T cells: contact residues for peptide- independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med 197:1345-1353.
31. Valsecchi R, Bontempelli M, Vicari O, Scudeller G, Cainelli T (1981) HLA antigens and contact sensitivity to para group. Ital Gen Rev Dermatol 18:99-103.
32. White SI, Friedmann PS, Stratton A (1986) HLA antigens and Langerhans cell density in contact dermatitis. Br J Dermatol 115:447-452.
33. Hegyi E, Busova B, Niks M (1990) HLA-A and -B antigens in IPPD- sensitive persons. Contact Dermat 22:228-229.
34. Wilkinson SM, Morrey K, Hollowood K, Heagerty AH, English JS (1993) HLA-A, -B and -DR antigens in hydrocortisone contact hypersensitivity. Contact Dermat 28: 295-297.
35. Friedmann PS (1991) Graded continuity, or all or nonestudies of the human immune response. Clin Exp Dermatol 16:79-84.
36. Moss C, Friedmann PS, Shuster S, Simpson JM (1985) Susceptibility and amplification of sensitivity in contact dermatitis. Clin Exp Immunol 61:232-241.
37. Carlsen BC, Menné T, Johansen JD (2007) 20 years of standard patch testing in an eczema population with focus on patients with multiple contact allergies. Contact Dermat 57:76-83.
38. Thyssen JP, Linneberg A, Menné T, Nielsen NH, Johansen JD (2009) Contact allergy to allergens of the TRUE test (panels 1 and 2) has decreased modestly in the general population. Br J Dermatol 161:1124-1129.
39. Jorde LB, Carey JC, Bamshad MJ, White RL (2006) Medical genetics, 3rd edn. Aufl, Mosby, St. Louis.
40. Reich K, Huffmeier U, Konig IR, Lascorz J, Lohmann J, Wendler J, Traupe H, Mossner R, Reis A, Burkhardt H (2007) TNF polymorphisms in psoriasis: Association of psoriatic arthritis with the promoter polymorphism TNF*- 857 independent of the PSORS1 risk allele. Arthritis Rheum 56:2056-2064.
41. Schnuch A, Westphal GA, Müller MM, Schulz TG, Geier J, Brasch J, Merk HF, Kawakubo Y, Richter G, Koch P, Fuchs Th, Gutgesell C, Reich K, Gebhardt M, Becker D, Grabbe J, Szliska C, Lischka G, Aberer W, Hallier E (1998) Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy. Contact Dermat 38:209-211.
42. Westphal GA, Reich K, Schulz TG, Neumann C, Hallier E, Schnuch A (2000) N-Acetyltransferases 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy. Br J Dermatol 142:1121-1127.
43. Westphal G-A, Schnuch A, Schulz T-G, Reich K, Aberer W, Brasch J, Koch P, Wessbecher R, Szliska C, Bauer A, Hallier E (2000) Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization. Int Arch Occup Environ Health 73:384-388.
44. Westphal G-A, Schnuch A, Moessner R, Koenig IR, Kränke B, Hallier E, Ziegler A, Reich K (2003) Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermat 48:93-98.
45. Reich K, Westphal G, König IR, Mössner R, Krüger U, Ziegler A, Neumann C, Schnuch A (2003) Association of allergic contact dermatitis with a promoter polymorphism in the IL16 gene. J All Clin Immunol 112:1191-1194.
46. Rustemeyer T, van-Hoogstraten IMW, von-Blomberg BME, Scheper RJ (2006) Mechanisms in allergic contact dermatitis. In: Frosch PJ, Menné T, Lepoittevin J-P (eds) Contact dermatitis, 4th edn. Aufl, Springer, Berlin, pp S11-S43.
47. Smith CK, Hotchkiss SAM (2001) Allergic contact dermatitis. Chemical and metabolic mechanisms. Taylor & Francis, London.
48. Schnuch A, Uter W, Reich K (2005) Allergic contact dermatitis and atopic eczema. In: Ring J, Przybilla B, Ruzicka T (Hrsg) Handbook of atopic eczema, Kapit. 17, 2nd Aufl. Springer, Berlin, pp S176-S199.
49. Wormhoudt LW, Commandeur JNM, Vermeulen NPE (1999) Genetic polymorphisms of human N-acetyltransferase, cytochrome p450, glutathione-S-transferase, and epoxide hydrolase enzymes. relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29:59-124.
50. Thier R, Bruning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM (2003) Markers of genetic susceptibility in human environmental hygiene and toxicology: The role of selected CYP, NAT and GST genes. Int J Hyg Environ Health 206:149-171.
51. Toebak MJ, Gibbs S, Bruynzeel DP, Scheper RJ, Rustemeyer T (2009) Dendritic cells: biology of the skin. Contact Dermat 60:2-20.
52. Jacobs JJ, Lehe CL, Hasegawa H, Elliott GR, Das PK (2006) Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 15:432-440.
53. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Durr C, Heimesaat MM, Bereswill S, Fejer G, Vassileva R, Jakob T, Freudenberg N, Termeer CC, Johner C, Galanos C, Freudenberg MA (2008) Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med 205:2151-2162.
54. Zepter K, Häffner A, Soohoo LF, De-Luca D, Tang HP, Fisher P, Chavinson J, Elmets CA (1997) Induction of biologically active IL-1-beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol 159:6203-6208.
55. Yazdi AS, Ghoreschi K, Rocken M (2007) Inflammasome activation in delayed-type hypersensitivity reactions. J Invest Dermatol 127:1853-1855.
56. Grabbe S, Steinert M, Mahnke K, Schwartz A, Luger TA, Schwarz T (1996) Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentrationdependent elicitation of allergic contact dermatitis. J Clin Invest 98:1158-1164.
57. Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I, Denis A, Nicolas JF, Hennino A (2007) Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 127:1430-1435.
58. Pedersen LK, Johansen JD, Held E, Agner T (2004) Augmentation of skin response by exposure to a combination of allergens and irritants - A review. Contact Dermat 50:265-273.
59. Smith HR, Basketter DA, McFadden JP (2002) Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol 27:138-146.
60. Clark IA (2007) How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev 18:335-343.
61. Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149-160.
62. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP (2008) Tumor necrosis factor antagonist mechanisms of action: A comprehensive review. Pharmacol Ther 117:244-279.
63. Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5:315-329.
64. Blömeke B, Brans R, Dickel H, Bruckner T, Erdmann S, Heesen M, Merk HF, Coenraads PJ (2009) Association between TNFA-308 G/A polymorphism and sensitization to paraphenylenediamine: A case-control study. Allergy 64:279-283.
65. Wang BJ, Shiao JS, Chen CJ, Lee YC, Guo YL (2007) Tumour necrotizing factor-alpha promoter and GST-T1 genotype predict skin allergy to chromate in cement workers in Taiwan. Contact Dermat 57:309-315.
66. Moraes MO, Duppre NC, Suffys PN, Santos AR, Almeida AS, Nery JAC, Sampaio EP, Sarno EN (2001) Tumor necrosis factor-alpha promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensitivity reaction in the skin of borderline tuberculoid leprosy patients. Immunogenetics 53:45-47.
67. Allen MH, Wakelin SH, Holloway D, Lisby S, Baadsgaard O, Barker JNWN, McFadden JP (2000) Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis. Immunogenetics 51: 201-205.
68. deJongh CM, John SM, Bruynzeel DP, Calkoen F, vanDijk FJ, Khrenova L, Rustemeyer T, Verberk MM, Kezic S (2008) Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermat 58:269-277.
69. Taudorf S, Krabbe KS, Berg RM, Moller K, Pedersen BK, Bruunsgaard H (2008) Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans. Clin Exp Immunol 152:147-152.
70. Kroeger KM, Steer JH, Joyce DA, Abraham LJ (2000) Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 12:110-119.
71. Heesen M, Kunz D, Bachmann-Mennenga B, Merk HF, Bloemeke B (2003) Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNFbeta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 31:211-214.
72. Stenzel A, Lu T, Koch WA, Hampe J, Guenther SM, DeLaVega FM, Krawczak M, Schreiber S (2004) Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum Genet 114:377-385.
73. Lio D, Candore G, Romano GC, D'Anna C, Gervasi F, DiLorenzo G, Modica MA, Potestio M, Caruso C (1997) Modification of cytokine patterns in subjects bearing the HLA-B8, DR3 phenotype: implications for autoimmunity. Cytokines Cell Mol Ther 3:217-224.
74. Glass WG, Sarisky RT, Vecchio AM (2006) Not-so-sweet sixteen: The role of IL-16 in infectious and immune-mediated inflammatory diseases. J Interferon Cytokine Res 26: 511-520.
75. Cruikshank WW, Kornfeld H, Center DM (2000) Interleukin-16. J Leukoc Biol 67:757-766.
76. Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DY, Hamid Q (1998) Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol 102:645-650.
77. Yoshimoto T, Wang CR, Yoneto T, Matsuzawa A, Cruikshank WW, Nariuchi H (2000) Role of IL-16 in delayed-type hypersensitivity reaction. Blood 95:2869-2874.
78. Masuda K, Katoh N, Soga F, Kishimoto S (2005) The role of interleukin-16 in murine contact hypersensitivity. Clin Exp Immunol 140:213-219.
79. Stoitzner P, Ratzinger G, Koch F, Janke K, Schöller T, Kaser A, Tilg H, Cruikshank WW, Fritsch P, Romani N (2001) Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent way. J Invest Dermatol 116:641-649.
80. Glas J, Torok HP, Unterhuber H, Radlmayr M, Folwaczny C (2003) The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin Immunol 106:197-200.
81. Reich K, Westphal G, Konig IR, Mossner R, Schupp P, Gutgesell C, Hallier E, Ziegler A, Neumann C (2003) Cytokine gene polymorphisms in atopic dermatitis. Br J Dermatol 148:1237-1241.
82. Burkart KM, Barton SJ, Holloway JW, Yang IA, Cakebread JA, Cruikshank W, Little F, Jin X, Farrer LA, Clough JB, Keith TP, Holgate S, Center DM, O'Connor GT (2006) Association of asthma with a functional promoter polymorphism in the IL16 gene. J Allergy Clin Immunol 117:86-91.
83. Akesson LS, Duffy DL, Phelps SC, Thompson PJ, Kedda MA (2005) A polymorphism in the promoter region of the human interleukin- 16 gene is not associated with asthma or atopy in an Australian population. Clin Exp Allergy 35:327-331.
84. Folwaczny M, Glas J, Torok HP, Tonenchi L, Paschos E, Malachova O, Bauer B, Folwaczny C (2005) Prevalence of the -295 T-to-C promoter polymorphism of the interleukin (IL)- 16 gene in periodontitis. Clin Exp Immunol 142:188-192.
85. Grant DM, Goodfellow GH, Sugamori KS, Durette K (2000) Pharmacogenetics of the human arylamine N-acetyltransferases. Pharmacology 61:204-211.
86. Agundez JA (2008) Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9:520-531.
87. Kawakubo Y, Merk HF, Masaoudi TA, Sieben S, Blomeke B (2000) N-Acetylation of paraphenylenediamine in human skin and keratinocytes. J Pharmacol Exp Ther 292:150-155.
88. Krasteva M, Nicolas J-F, Chabeau G, Garrigue J-L, Bour H, Thivolet J, Schmitt D (1993) Dissociation of allergenic and immunogenic functions in contact sensitivity to paraphenylenediamine. Int Arch Allergy Immunol 102:200-204.
89. Lisi P, Hansel K (1998) Is benzoquinone the prohapten in cross - sensitivity among aminobenzene compounds? Contact Dermat 39:304-306.
90. White JM, Kullavanijaya P, Duangdeeden I, Zazzeroni R, Gilmour NJ, Basketter DA, McFadden JP (2006) p-Phenylenediamine allergy: The role of Bandrowski's base. Clin Exp Allergy 36:1289-1293.
91. Goebel C, Hewitt NJ, Kunze G, Wenker M, Hein DW, Beck H, Skare J (2009) Skin metabolism of aminophenols: Human keratinocytes as a suitable in vitro model to qualitatively predict the dermal transformation of 4-amino-2- hydroxytoluene in vivo. Toxicol Appl Pharmacol 235: 114-123.
92. Aeby P, Sieber T, Beck H, Gerberick GF, Goebel C (2009) Skin sensitization to p-phenylenediamine: The diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. J Invest Dermatol 129:99-109.
93. Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, Blomeke B (2002) Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol 109:1005-1011.
94. Coulter EM, Jenkinson C, Wu Y, Farrell J, Foster B, Smith A, McGuire C, Pease C, Basketter D, King C, Friedmann PS, Pirmohamed M, Park BK, Naisbitt DJ (2008) Activation of T-cells from allergic patients and volunteers by p-phenylenediamine and Bandrowski's base. J Invest Dermatol 128:897-905.
95. Ladero JM (2008) Influence of polymorphic N-acetyltransferases on non-malignant spontaneous disorders and on response to drugs. Curr Drug Metab 9:532-537.
96. Orzechowska-Juzwenko K, Milejski P, Patkowski J, Nittner- Marszalska M, Malolepszy J (1990) Acetylator phenotype in patients with allergic diseases and its clinical significance. Int J Clin Pharmacol Therap Toxicol 28:420-425.
97. Kosmadakis G, Bulovskaya L, Rudinski K, Lintsov A (1996) Acetylator phenotype in patients with bronchial asthma. Eur J All Clin Immunol 51(30 Suppl):70.
98. Zielinska E, Niewiarowski W, Bodalski J, Stanczyk A, Bolanowski W, Rebowski G (1997) Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases. Clin Pharmacol Ther 62:635-642.
99. Gawronska-Szklarz B, Luszawska-Kutrzeba T, Czaja- Bulsa G, Kurzawski G (1999) Relationship between acetylation polymorphism and risk of atopic diseases. Clin Pharmacol Ther 65:562-569.
100. Brocvielle H, Muret P, Goydadin A-C, Boone P, Broly F, Kantelip J-P, Humbert P (2003) N-Acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects. Skin Pharmacol Appl Skin Physiol 16:386-392.
101. Olszewska Z, Jablkowska-Gajdzinska J, Majewska E (1984) Acetylation phenotype in patients with eczema. Prezeg Dermatol LXXI:213-214.
102. Kawakubo Y, Nakamori M, Schoepf E, Ohkido M (1995) Acetylator phenotyping in patients with p-phenylenediamine (PPD) allergy. Skin Pharmacol 8(11):273.
103. Kawakubo Y, Nakamori M, Schöpf E, Ohkido M (1997) Acetylator phenotype in patients with p-phenylenediamine allergy. Dermatology 195:43-45.
104. Nacak M, Erbagci Z, Aynacioglu AS (2006) Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis. Int J Dermatol 45: 323-326.
105. Najim RA, Al-waizt M, Al-Razzuqi RA (2005) Acetylator phenotype in Iraqi patients with allergic contact dermatitis. Ann Saudi Med 25:473-476.
106. Butcher NJ, Ilett KF, Minchin RF (2000) Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p- Aminobenzoic acid. Biochem Pharmacol 60:1829-1836.
107. Butcher NJ, Ilett KF, Minchin RF (2000) Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 57:468-473.
108. Gillam EMJ (2001) The dark side of a 'detoxification' mechanism. Trends Pharmacol Sci 22:11.
109. Bolt HM, Thier R (2006) Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 7:613-628.
110. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51-88.
111. Ates NA, Tursen U, Tamer L, Kanik A, Derici E, Ercan B, Atik U (2004) Glutathione S-transferase polymorphisms in patients with drug eruption. Arch Dermatol Res 295:429-433.
112. Brasch-Andersen C, Christiansen L, Tan Q, Haagerup A, Vestbo J, Kruse TA (2004) Possible gene dosage effect of glutathione- S-transferases on atopic asthma: using realtime PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum Mutat 24:208-214.
113. Holla LI, Stejskalova A, Vasku A (2006) Polymorphisms of the GSTM1 and GSTT1 genes in patients with allergic diseases in the Czech population. Allergy 61:265-267.
114. Lira MG, Provezza L, Malerba G, Naldi L, Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Alaibac M, Turco A, Girolomoni G, Tessari G (2006) Glutathione S-transferase and CYP1A1 gene polymorphisms and nonmelanoma skin cancer risk in Italian transplanted patients. Exp Dermatol 15:958-965.
115. Bohets HH, Van Thielen MN, VanderBiest I, Van Landeghem GF, D'Haese PC, Nouwen EJ, DeBroe ME, Dierickx PJ (1995) Cytotoxicity of mercury compounds in LLC-PK1, MDCK and human proximal tubular cells. Kidney Int 47:395-403.
116. Almar MM, Dierickx PJ (1990) In vitro interaction of mercury, copper (II) and cadmium with human glutathione transferase pi. Res Commun Chem Pathol Pharmacol 69:99-102.
117. Santucci B, Cannistraci C, Cristaudo A, Camera E, Picardo M (1998) Thimerosal positivities: The role of SH groups and divalent ions. Contact Dermat 39:123-126.
118. Picardo M, Zompetta C, Marchese C, de Luca C, Faggioni A, Schmidt RJ, Santucci B (1992) Paraphenylenediamine, a contact allergen, induces oxidative stress and ICAM-1 expression in human keratinocytes. Br J Dermatol 126: 450-455.
119. Valko M, Morris H, Cronin MT (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12:1161-1208.
120. Kaur S, Zilmer M, Eisen M, Rehema A, Kullisaar T, Vihalemm T, Zilmer K (2004) Nickel sulphate and epoxy resin: differences in iron status and glutathione redox ratio at the time of patch testing. Arch Dermatol Res 295:517-520.
121. Rutault K, Alderman C, Chain BM, Katz DR (1999) Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 26:232-238.
122. Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd SL, Terlecky SR (2008) Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 128:2606-2614.
123. Mizuashi M, Ohtani T, Nakagawa S, Aiba S (2005) Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J Invest Dermatol 124: 579-586.
124. Bruchhausen S, Zahn S, Valk E, Knop J, Becker D (2003) Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers. J Invest Dermatol 121: 1039-1044.
125. Kalergis AM, Lopez CB, Becker MI, Diaz MI, Sein J, Garbarino JA, De Ioannes AE (1997) Modulation of fatty acid oxidation alters contact hypersensitivity to urushiols: role of aliphatic chain beta-oxidation in processing and activation of urushiols. J Invest Dermatol 108:57-61.
126. Christensson JB, Matura M, Backtorp C, Borje A, Nilsson JL, Karlberg AT (2006) Hydroperoxides form specific antigens in contact allergy. Contact Dermat 55:230-237.
127. Bag A, Bag N (2008) Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: A review. Cancer Epidemiol Biomark Prev 17:3298-3305.
128. Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Hu CJ, Liu HW (2003) Manganese superoxide dismutase and cytochrome P450 1A1 genes polymorphisms in rheumatoid arthritis in Taiwan. Hum Immunol 64:366-373.
129. Mak JC, Leung HC, Ho SP, Ko FW, Cheung AH, Ip MS, Chan-Yeung MM (2006) Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy 36:440-447.
130. Brans R, Dickel H, Bruckner T, Coenraads PJ, Heesen M, Merk HF, Blomeke B (2005) MnSOD polymorphisms in sensitized patients with delayed-type hypersensitivity reactions to the chemical allergen para-phenylene diamine: A case-control study. Toxicology 212:148-154.
131. Scholzen TE, König S, Fastrich M, Bohm M, Luger TA (2007) Terminating the stress: peripheral peptidolysis of proopiomelanocortin-derived regulatory hormones by the dermal microvascular endothelial cell extracellular peptidases neprilysin and angiotensin-converting enzyme. Endocrinology 148:2793-2805.
132. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81-96.
133. Scholzen TE, Stander S, Riemann H, Brzoska T, Luger TA (2003) Modulation of cutaneous inflammation by angiotensin- converting enzyme. J Immunol 170:3866-3873.
134. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346.
135. Nacak M, Erbagci Z, Buyukafsar K, Yurtsever AS, Tiftik RN (2007) Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with allergic contact dermatitis. Basic Clin Pharmacol Toxicol 101:101-103.
136. Masek K, Slansky J, Petrovicky P, Hadden JW (2003) Neuroendocrine immune interactions in health and disease. Int Immunopharmacol 3:1235-1246.
137. Hendrix S (2008) Neuroimmune communication in skin: far from peripheral. J Invest Dermatol 128:260-261.
138. Frazer KA, Murray SS, Schork NJ, Topol EJ (2009) Human genetic variation and its contribution to complex traits. Nat Rev Genet 10:241-251.
139. Brown SJ, McLean WHI (2009) Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 129:543-552.
140. Sandilands A, Smith FJ, Irvine AD, McLean WH (2007) Filaggrin's fuller figure: A glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 127:1282-1284.
141. Kezic S, Kemperman PM, Koster ES, deJongh CM, Thio HB, Campbell LE, Irvine AD, McLean WHI, Puppels GJ, Caspers PJ (2008) Loss-of-function muations in the filaggrin gene lead to reduced level of natural moisterizing factor in the stratum corneum. J Invest Dermatol 128:2117-2119.
142. Irvine AD, McLean WH (2006) Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 126:1200-1202.
143. O'Regan GM, Sandilands A, McLean WH, Irvine AD (2008) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 122:689-693.
144. Brown SJ, Relton CL, Liao H, Zhao Y, Sandilands A, Wilson IJ, Burn J, ReynoldsNJ, McLean WH, Cordell HJ (2008) Filaggrin null mutations and childhood atopic eczema: A population-based case-control study. J Allergy Clin Immunol 121:940-946.e3.
145. Weidinger S, O'Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, Ruether A, Klopp N, Vogelberg C, Weiland SK, McLean WH, von Mutius E, Irvine AD, Kabesch M (2008) Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 121: 1203-1209.e1.
146. Baurecht H, Irvine AD, Novak N, Illig T, Buhler B, Ring J, Wagenpfeil S, Weidinger S (2007) Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 120:1406-1412.
147. Nemoto-Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WH, Shimizu H (2009) Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol 129:632-639.
148. de Jongh CM, Khrenova L, Verberk MM, Calkoen F, van Dijk FJ, Voss H, John SM, Kezic S (2008) Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: A case- control study. Br J Dermatol 159:621-627.
149. Lerbaek A, Bisgaard H, Agner T, Ohm-Kyvik K, Palmer CN, Menne T (2007) Filaggrin null alleles are not associated with hand eczema or contact allergy. Br J Dermatol 157:1199-1204.
150. Brown SJ, Cordell HJ (2008) Are filaggrin mutations associated with hand eczema or contact allergy?-we do not know. Br J Dermatol 158:1383-1384.
151. Weidinger S, Rodriguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, Novak N (2007) Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 127:724-726.
152. Novak N, Baurecht H, Schäfer T, Rodriguez E, Wagenpfeil S, Klopp N, Heinrich J, Behrendt H, Ring J, Wichmann E, Illig T, Weidinger S (2008) Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 128:1430-1435.
153. Nielsen NH, Menne T (1992) Allergic contact sensitization in an unselected danish population - The Glostrup allergy study, Denmark. Acta Derm Venereol (Stockh) 72: 456-460.
154. Nielsen NH, Linneberg A, Menne T, Maden F, Frolund L, Dirksen A, Jorgensen T (2001) Allergic contact sensitization in an adult Danish population: Two cross-sectional surveys eight years apart (The Copenhagen Allergy Study). Acta Derm Venereol 81:31-34.
155. Schnuch A, Uter W, Geier J, Gefeller O (2002) Epidemiology of contact allergy: An estimation of morbidity employing the clinical epidemiology and drug utilisation research (CE-DUR) approach. Contact Dermat 47:32-39.
156. Uter W, Ludwig A, Balda B-R, Schnuch A, Pfahlberg A, Schäfer T, Wichmann H-E, Ring J (2004) The prevalence of contact allergy differed between population-based and clinic-based data. J Clin Epidemiol 57:627-632.
157. Schnuch A, Geier J, Uter W, Frosch PJ, Lehmacher W, Aberer W, Agathos M, Arnold R, Fuchs T, Laubstein B, Lischka G, Pietrzyk PM, Rakoski J, Richter G, Rueff F (1997) National rates and regional differences in sensitization to allergens of the standard series. Population adjusted frequencies of sensitization (PAFS) in 40.000 patients from a multicenter study (IVDK). Contact Dermat 37:200-209.
158. Schnuch A, Lessmann H, Geier J, Frosch PJ, Uter W (2004) Contact allergy to fragrances: frequencies of sensitization from 1996 to 2002. Results of the IVDK. Contact Dermat 50:65-76.
159. Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154-166.
160. Cumberbatch M, Dearman RJ, Kimber I (1997) Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 92: 388-395.
161. Bartee E, Mohamed MR, McFadden G (2008) Tumor necrosis factor and interferon: cytokines in harmony. Curr Opin Microbiol 11:378-383.
162. Reich K, Westphal G, Schulz T, Müller M, Zipprich S, Fuchs T, Hallier E, Neumann C (1999) Evidence for a synergistic effect of polymorphisms of N-actetyltransferase 2 and TNF- Alpha promoter as susceptibility factors for psoriasis in males. J Invest Dermatol 113:214-220.
163. Balding DJ (2006) A tutorial on statistical methods for population association studies. Nat Rev Genet 7:781-791.
164. Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118:1590-1605.
165. Wallace HJ, Vandongen YK, Stacey MC (2006) Tumor necrosis factor-alpha gene polymorphism associated with increased susceptibility to venous leg ulceration. J Invest Dermatol 126:921-925.
166. Willis CM (2002) Variability in responsiveness to irritants: Thoughts on possible underlying mechanisms. Contact Dermat 47:267-271.
167. Uter W, Geier J, Pfahlberg A, Effendy I (2002) The spectrum of contact allergy in elderly patients with and without lower leg dermatitis. Dermatology 204:266-272.
168. Descotes J (1988) Immunotoxicology of drugs and chemicals. Elsevier, Amsterdam, New York, Oxford.
169. Elliott JC, Picker MJ, Nelson CJ, Carrigan KA, Lysle DT (2003) Sex differences in opioid-induced enhancement of contact hypersensitivity. J Invest Dermatol 121:1053-1059.
170. Uter W, Hegewald J, Kranke B, Schnuch A, Gefeller O, Pfahlberg A (2008) The impact of meteorological conditions on patch test results with 12 standard series allergens (fragrances, biocides, topical ingredients). Br J Dermatol 158:734-739.
171. Saint-Mezard P, Chavagnac C, Bosset S, Ionescu M, Peyron E, Kaiserlian D, Nicolas JF, Berard F (2003) Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 171:4073-4080.
172. Choi EH, Brown BE, Crumrine D, Chang S, Man MQ, Elias PM, Feingold KR (2005) Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 124:587-595.
173. Lübbe D, Fiedler H (1991) Experimentelle DNCBKontaktallergie, eine 10-Jahresstudie bei 137 Probanden. Z Hautkr 66:954-956.
174. Rees JL, Friedmann PS, Matthews JNS (1989) Sex differences in susceptibility to development of contact hypersensitivity to dinitrochlorobenzene (DNCB). Br J Dermatol 120:371-374.
175. Kwangsukstith C, Maibach HI (1995) Effect of age and sex on the induction and elicitation of allergic contact dermatitis. Contact Dermat 33:289-298.
176. Kligman AM (1966) The identification of contact allergens by human assay: II. Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol 47:375-391.
177. DeLeo VA, Taylor S, Belsito DV, Fowler JF Jr, Fransway AF, Maibach HI, Marks JG Jr, Mathias T, Nethercott J, Pratt MD, Rietschel RL, Sherertz EF, Storrs FJ, Taylor J (2000) North American Contact Dermatitis Group patch test results: ethnic differences. Am J Contact Derm 11:197.
178. Dickel H, Taylor JS, Evey P, Merk HF (2001) Comparison of patch test results with a standard series among white and black racial groups. Am J Contact Dermat 12:77-82.
179. Chase MW (1941) Inheritance in Guinea pigs of the susceptibility to skin sensitization with simple chemical compounds. J Exp Med 73:711-726.
180. Polak L, Barnes M, Turk JL (1968) The genetic control of contact densitization to inorganic metal compounds in guinea pigs. Immunology 14:707-711.
181. Asherson GL, Dieli F, Gautam Y, Siew LK, Zembala M (1990) Major histocompatibility complex regulation of the class of the immune response: The H-2d haplotype determines poor interferon-gamma response to several antigens. Eur J Immunol 20:1305-1310.
182. Basketter DA, Griffiths HA, Wang XM, Wilhelm KP, McFadden J (1996) Individual, ethnic and seasonal variability in irritant susceptibility of skin: The implications for a predictive human patch test. Contact Dermat 35:208-213.
183. Lammintausta K, Maibach HI, Wilson D (1987) Irritant reactivity in males and females. Contact Dermat 17:276-280.
184. Judge MR, Griffiths HA, Basketter DA, White IR, Rycroft RJ, McFadden JP (1996) Variation in response of human skin to irritant challenge. Contact Dermat 34:115-117.
185. Holst R, Moller H (1975) One hundred twin pairs patch tested with primary irritants. Br J Dermatol 93:145-149.
186. de Jongh CM, Verberk MM, Withagen CE, Jacobs JJ, Rustemeyer T, Kezic S (2006) Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermat 54:325-333.
187. de Jongh CM, Jakasa I, Verberk MM, Kezic S (2006) Variation in barrier impairment and inflammation of human skin as determined by sodium lauryl sulphate penetration rate. Br J Dermatol 154:651-657.
188. Agner T, Serup J (1990) Individual and instrumental variations in irritant patch-test reactions-clinical evaluation and quantification by bioengineering methods. Clin Exp Dermatol 15:29-33.
189. Pinnagoda J, Tupker RA, Smit JA, Coenraads PJ, Nater JP (1989) The intra- And inter-individual variability and reliability of transepidermal water loss measurements. Contact Dermat 21:255-259.
190. Robinson MK, Perkins MA, Basketter DA (1998) Application of a 4-h human patch test method for comparative and investigative assessment of skin irritation. Contact Dermat 38:194-202.
191. Smith HR, Holloway D, Armstrong DK, Basketter DA, McFadden JP (2000) Irritant thresholds in subjects with colophony allergy. Contact Dermat 42:95-97.
192. Smith HR, Armstrong DK, Holloway D, Whittam L, Basketter DA, McFadden JP (2002) Skin irritation thresholds in hairdressers: implications for the development of hand dermatitis. Br J Dermatol 146:849-852.
193. Smith HR, Kelly DA, Young AR, Basketter DB, McFadden JP (2002) Relationship between 2, 4-dinitrochlorobenzene elicitation responses and individual irritant threshold. Contact Dermat 46:97-100.
194. McFadden JP, Basketter DA (2000) Contact allergy, irritancy and 'danger'. Contact Dermat 42:123-127.
195. McLelland J, Shuster S, Matthews JN (1991) 'Irritants' increase the response to an allergen in allergic contact dermatitis. Arch Dermatol 127:1016-1019.
196. Kligman AM (1966) The identification of contact allergens by human assay. II. Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol 47:375-392.
197. Marrakchi S, Maibach HI (2006) Sodium lauryl sulfateinduced irritation in the human face: regional and agerelated differences. Skin Pharmacol Physiol 19:177-180.
198. Tupker RA, Coenraads PJ, Pinnagoda J, Nater JP (1989) Baseline transepidermal water loss (TEWL) as a prediction of susceptibility to sodium lauryl sulphate. Contact Dermat 20:265-269.
199. Agner T (1991) Skin susceptibility in uninvolved skin of hand eczema patients and healthy controls. Br J Dermatol 125:140-146.
200. Berardesca E, Maibach HI (1988) Sodium-lauryl-sulphateinduced cutaneous irritation. Comparison of white and Hispanic subjects. Contact Dermat 19:136-140.
201. Tupker RA, Pinnagoda J, Coenraads PJ, Nater JP (1990) Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis. Br J Dermatol 123:199-205.
202. Wilhelm KP, Maibach HI (1990) Susceptibility to irritant dermatitis induced by sodium lauryl sulfate. J Am Acad Dermatol 23:122-124.
203. Di Nardo A, Sugino K, Wertz P, Ademola J, Maibach HI (1996) Sodium lauryl sulfate (SLS) induced irritant contact dermatitis: A correlation study between ceramides and in vivo parameters of irritation. Contact Dermat 35:86-91.
204. de Jongh CM, Lutter R, Verberk MM, Kezic S (2007) Differential cytokine expression in skin after single and repeated irritation by sodium lauryl sulphate. Exp Dermatol 16:1032-1040.
205. Werner Y, Lindberg M (1985) Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 65:102-105.
206. Agner T (1991) Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulphate. Acta Derm Venereol 71:296-300.
207. Cowley NC, Farr PM (1992) A dose-response study of irritant reactions to sodium lauryl sulphate in patients with seborrhoeic dermatitis and atopic eczema. Acta Derm Venereol 72:432-435.
208. Loffler H, Effendy I (1999) Skin susceptibility of atopic individuals. Contact Dermat 40:239-242.
209. Basketter DA, Miettinen J, Lahti A (1998) Acute irritant reactivity to sodium lauryl sulfate in atopics and nonatopics. Contact Dermat 38:253-257.
210. Tupker RA, Coenraads PJ, Fidler V, De Jong MC, Van der Meer JB, De Monchy JG (1995) Irritant susceptibility and weal and flare reactions to bioactive agents in atopic dermatitis. I. Influence of disease severity. Br J Dermatol 133:358-364.
211. Jakasa I, de Jongh CM, Verberk MM, Bos JD, Kezic S (2006) Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 155:104-109.
212. Proksch E, Folster-Holst R, Jensen JM (2006) Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 43:159-169.
213. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, Digiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El HB, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-446.
214. Pastore S, Corinti S, La PM, Didona B, Girolomoni G (1998) Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol 101:538-544.
215. de Vries I, Langeveld-Wildschut EG, van Reijsen FC, Dubois GR, van den Hoek JA, Bihari IC, van WD, de Weger RA, Knol EF, Thepen T, Bruijnzeel-Koomen CA (1998) Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol 102:461-468.
216. Schnuch A, Uter W, Reich K (2005) Allergic contact dermatitis and atopic eczema. In: Ring J, Przybilla B, Ruzicka T (eds) Handbook of atopic eczema. Springer, Berlin, Heidelberg, New York, pp 176-199.
217. Kiyohara C, Tanaka K, Miyake Y (2008) Genetic susceptibility to atopic dermatitis. Allergol Int 57:39-56.
218. Brown SJ, McLean WH (2009) Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 129: 543-552.
219. Reed JT, Ghadially R, Elias PM (1995) Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol 131:1134-1138.
220. Wilhelm KP, Cua AB, Maibach HI (1991) Skin aging. Effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content. Arch Dermatol 127:1806-1809.
221. Goh CL, Chia SE (1988) Skin irritability to sodium lauryl sulphate-as measured by skin water vapour loss-by sex and race. Clin Exp Dermatol 13:16-19.
222. Harvell J, Hussona-Saeed I, Maibach HI (1992) Changes in transepidermal water loss and cutaneous blood flow during the menstrual cycle. Contact Dermat 27:294-301.
223. Agner T, Damm P, Skouby SO (1991) Menstrual cycle and skin reactivity. J Am Acad Dermatol 24:566-570.
224. Robinson MK (2002) Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons. Contact Dermat 46:86-93.
225. Uter W, Geier J, Becker D, Brasch J, Loffler H (2004) The MOAHLFA index of irritant sodium lauryl sulfate reactions: first results of a multicentre study on routine sodium lauryl sulfate patch testing. Contact Dermat 51:259-262.
226. Cua AB, Wilhelm KP, Maibach HI (1990) Cutaneous sodium lauryl sulphate irritation potential: Age and regional variability. Br J Dermatol 123:607-613.
227. Schwindt DA, Wilhelm KP, Miller DL, Maibach HI (1998) Cumulative irritation in older and younger skin: A comparison. Acta Derm Venereol 78:279-283.
228. Suh DH, Youn JI, Eun HC (2001) Effects of 12-O-tetradecanoylphorbol- 13-acetate [corrected] and sodium lauryl sulfate on the production and expression of cytokines and proto-oncogenes in photoaged and intrinsically aged human keratinocytes. J Invest Dermatol 117:1225-1233.
229. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM (1995) The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 95:2281-2290.
230. Modjtahedi SP, Maibach HI (2002) Ethnicity as a possible endogenous factor in irritant contact dermatitis: comparing the irritant response among Caucasians, blacks, and Asians. Contact Dermat 47:272-278.
231. Robinson MK (2000) Racial differences in acute and cumulative skin irritation responses between Caucasian and Asian populations. Contact Dermat 42:134-143.
232. Foy V, Weinkauf R, Whittle E, Basketter DA (2001) Ethnic variation in the skin irritation response. Contact Dermat 45:346-349.
233. Weigand DA, Gaylor JR (1974) Irritant reaction in Negro and Caucasian skin. South Med J 67:548-551.
234. Astner S, Burnett N, Rius-Diaz F, Doukas AG, Gonzalez S, Gonzalez E (2006) Irritant contact dermatitis induced by a common household irritant: A noninvasive evaluation of ethnic variability in skin response. J Am Acad Dermatol 54:458-465.
235. Hicks SP, Swindells KJ, Middelkamp-Hup MA, Sifakis MA, Gonzalez E, Gonzalez S (2003) Confocal histopathology of irritant contact dermatitis in vivo and the impact of skin color (black vs white). J Am Acad Dermatol 48:727-734.
236. Berardesca E, Maibach H (2003) Ethnic skin: overview of structure and function. J Am Acad Dermatol 48: S139-S142.
237. Van der V, Nater JP, Bleumink E (1985) Vulnerability of the skin to surfactants in different groups of eczema patients and controls as measured by water vapour loss. Clin Exp Dermatol 10:98-103.
238. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G (2001) Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 144:549-556.
239. Johnson MW, Maibach HI, Salmon SE (1971) Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N Engl J Med 284: 1255-1257.
240. Van der Valk, Maibach HI (1989) Potential for irritation increases from the wrist to the cubital fossa. Br J Dermatol 121:709-712.
241. McFadden JP, Wakelin SH, Basketter DA (1998) Acute irritation thresholds in subjects with type I-type VI skin. Contact Dermat 38:147-149.
242. Frosch PJ, Wissing C (1982) Cutaneous sensitivity to ultraviolet light and chemical irritants. Arch Dermatol Res 272:269-278.
243. Loffler H, Aramaki JU, Effendy I (2002) The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol 8:19-22.
244. de Jongh CM, John SM, Bruynzeel DP, Calkoen F, van Dijk FJ, Khrenova L, Rustemeyer T, Verberk MM, Kezic S (2008) Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermat 58: 269-277.
245. Allen MH, Wakelin SH, Holloway D, Lisby S, Baadsgaard O, Barker JN, McFadden JP (2000) Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis. Immunogenetics 51:201-205.
246. Corsini E, Galli CL (2000) Epidermal cytokines in experimental contact dermatitis. Toxicology 142:203-211.
247. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf- Lafontaine N, Roland S, Mahieu P, Malaise M, De GD, Louis R, Belaiche J (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113:401-406.
248. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199.
249. Hollegaard MV, Bidwell JL (2006) Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun 7:269-276.
250. Castro J, Telleria JJ, Linares P, Blanco-Quiros A (2000) Increased TNFA*2, but not TNFB*1, allele frequency in Spanish atopic patients. J Investig Allergol Clin Immunol 10:149-154.
251. Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi LM, Biunno I (2002) Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 54:82-86.
252. de Jongh CM, Khrenova L, Kezic S, Rustemeyer T, Verberk MM, John SM (2008) Polymorphisms in the interleukin-1 gene influence the stratum corneum interleukin- 1 alpha concentration in uninvolved skin of patients with chronic irritant contact dermatitis. Contact Dermat 58:263-268.
253. Nemoto-Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WI, Shimizu H (2009) Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol 129:682-689.
254. Kezic S, Kemperman PM, Koster ES, de Jongh CM, Thio HB, Campbell LE, Irvine AD, McLean IW, Puppels GJ, Caspers PJ (2008) Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 128:2117-2119.
255. de Jongh CM, Khrenova L, Verberk MM, Calkoen F, van Dijk FJ, Voss H, John SM, Kezic S (2008) Loss-offunction polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: A case-control study. Br J Dermatol 159:621-627.
256. Rodriguez E, Illig T, Weidinger S (2008) Filaggrin loss-offunction mutations and association with allergic diseases. Pharmacogenomics 9:399-413.
257. Uter W, Hegewald J, Pfahlberg A, Pirker C, Frosch PJ, Gefeller O (2003) The association between ambient air conditions (temperature and absolute humidity), irritant sodium lauryl sulfate patch test reactions and patch test reactivity to standard allergens. Contact Dermat 49: 97-102.
258. Loffler H, Happle R (2003) Influence of climatic conditions on the irritant patch test with sodium lauryl sulphate. Acta Derm Venereol 83:338-341.
259. Pedersen LK, Johansen JD, Held E, Agner T (2004) Augmentation of skin response by exposure to a combination of allergens and irritants - A review. Contact Dermat 50:265-273.
260. McMullen E, Gawkrodger DJ (2006) Physical friction is under-recognized as an irritant that can cause or contribute to contact dermatitis. Br J Dermatol 154:154-156.